chore: daily update 2026-07-30
This commit is contained in:
OpenWiki Bot
+1
-1
@@ -1,5 +1,5 @@
|
||||
{
|
||||
"updatedAt": "2026-07-28T18:10:15.764Z",
|
||||
"updatedAt": "2026-07-29T18:13:32.946Z",
|
||||
"command": "update",
|
||||
"model": "MiniMax-M3"
|
||||
}
|
||||
|
||||
@@ -25,6 +25,20 @@ Concrete work tasks, follow-ups, approvals, and scheduled items extracted from G
|
||||
- Status: open
|
||||
- Notes: Single primary source (BetaLife SG LinkedIn) but the regulation itself is a published policy text — Order No. 818 creates an accelerated clinical-translation pathway at qualified hospitals for cell therapy and 3D bioprinting after demonstrating safety and preliminary efficacy. This is **the clinical-translation counterpart** to the existing `china-cde-cell-gene-therapy-rules-2026` item (which is about classification / CMC planning). Both items matter: classification scope drives dossier content vendors need to assemble; the clinical-translation pathway drives which hospitals can host first-in-human studies. Pull the NMPA / State Council Order No. 818 direct text before the next vendor sync; check whether any active CellShot-TriArm or ClinoReactor-class deal depends on whether the buyer hospital qualifies as a "qualified hospital" under the regulation.
|
||||
|
||||
### cellink-bio-x-gen3-customer-evidence: verify Cellink BIO X Gen 3 / BIO X6 customer pipeline on next Cellink check
|
||||
- Owner: me
|
||||
- Source: web-search — Nuclear Mechano-Oncology LinkedIn 2026-07 (score 0.601; "our new BIO X Gen 3 bioprinter has now been installed … first hands-on training session"); CELLINK official LinkedIn 2026-07-28 (score 0.287; BIO X6 at University of Miami 3D Bioprinting Facility); third-party market report LinkedIn 2026-07-28 (score 0.659; Cellink revenue uptick following strategic acquisitions); appellaser.ro practical selection guide 2026-07-24 (score 0.303; BIO X Gen 3 general-purpose positioning)
|
||||
- Due: unscheduled
|
||||
- Status: open
|
||||
- Notes: First vendor-anchored Cellink signal in any Tavily pull after 5 prior pulls of zero Cellink product mentions. Four distinct sources: customer install LinkedIn (Eastern Europe), vendor LinkedIn (CELLINK U. Miami), market report, independent selection guide. Verify with Cellink whether the BIO X Gen 3 / BIO X6 nomenclature is current product naming or if one is being deprecated; whether any of the named customer accounts (Nuclear Mechano-Oncology; U. Miami 3D Bioprinting Facility) maps to active Chinese pharma R&D / CDMO opportunities. Companion to the existing `celvivo-clinoreactor-thewell-bioscience-xeno-free` item.
|
||||
|
||||
### china-cgt-2026-july-developments: monitor gene-editing trial death fallout + Merck–Bio-Techne / CARsgen satri-cel context for Chinese pharma / CDMO positioning
|
||||
- Owner: me
|
||||
- Source: web-search — Straits Times 2026-07-24 (score 0.313; patient death in China gene-editing trial draws fire); LiveScience 2026-07-24 (score 0.145; 6-year-old girl, investigation into gene-therapy regulations); SCMP 2026-07-29 (score 0.203; "Fear of policy backlash" — same-day coverage with this Tavily pull); Roots Analysis 2026-07-24 (score 0.669; Merck–Bio-Techne $11.3B acquisition June 2026 + CARsgen satri-cel CAR-T approval for stomach cancer June 2026); BioSpace 2026-07-27 (score 0.535; Summit/Merck China-first regulatory navigation)
|
||||
- Due: unscheduled
|
||||
- Status: open
|
||||
- Notes: Material new development in the China regulatory lane — sits **on top of** the existing `china-cde-cell-gene-therapy-rules-2026` and `china-order-no-818-clinical-translation` items, not replacing them. Two positive signals (Merck–Bio-Techne acquisition; CARsgen satri-cel solid-tumor CAR-T approval) show the China CGT manufacturing environment is consolidating around advanced therapeutics. One negative signal (gene-editing trial death + published regulatory backlash) could foreshadow stricter CDE / NMPA / hospital-level oversight and tighter qualification criteria for "qualified hospitals" under Order No. 818. Together these affect: (a) qualification timelines for the CellShot-TriArm and ClinoReactor-class deals Robin has in flight, (b) which "qualified hospitals" remain eligible to host first-in-human studies, (c) whether CelVivo / 3Brain / Cellink vendor positioning for Chinese pharma R&D / CDMO accounts needs to change tone (e.g. emphasize safety documentation, IRB-grade workflows). Pull NMPA / hospital-IRB statements on the gene-editing trial case before next Chinese customer conversation.
|
||||
|
||||
<!--
|
||||
Structure for new entries:
|
||||
|
||||
|
||||
+4
-4
@@ -23,7 +23,7 @@
|
||||
|
||||
- **Wiki state:** initialized — Hacker News, the local Obsidian vault, and Tavily web search are active and feeding `/sources/hackernews.md`, `/sources/git-repo.md`, `/sources/web-search.md`, and `/themes.md`.
|
||||
- **Connectors:** Hacker News, git-repo, and web search active. Gmail, Slack, Notion, and X are not yet configured — see "Adding sources" below.
|
||||
- **Last update:** see [/.last-update.json](/.last-update.json) — this run was a `git-repo` refresh (`obsidian-robin-1` pulled 2026-07-28 18:07 UTC). The Obsidian vault HEAD advanced from `62877d1f` (2026-07-22) to `21491578` (2026-07-28), with **4 new commits on `main`** (all dated 2026-07-28): Hodge 2025 RegenMed Bio-Block MSC 4-week comparison, Lee 2025 Front Vet Sci canine MSC 3D spheroid (Wiki.js + NocoDB-linked), Parate 2020 PEMF MSC paracrine cartilage, and a new CelVivo distributor technical-contact profile (`02-Clients/Agents/董慧群.md`) — the latter is the first entry in the new `02-Clients/Agents/` bucket and most fields (agency, region, contact, served customers) are still 待补. The 5 untracked files from the prior pull (Raji 2026, Tasevska 2025, Bosnjakovic 2025, PressNet 2026-07-07, OpenWiki cheat sheet) carry over unchanged; the `skills/openclaw-workspace` submodule now reports a `-dirty` suffix (hash unchanged, no content delta). All four new commits are inside the 7-day "vault fresh" window so no `commitments.md` "vault fresh" row fires. The 董慧群 profile's open fields are logged as a new Active entry on `/open-questions.md` (`agent-dong-huiqun-celvivo`) so future agents can reason about CelVivo-channel activity once Robin fills them in. Detailed manifest + structural index in `/sources/git-repo.md`.
|
||||
- **Last update:** see [/.last-update.json](/.last-update.json) — this run was a `git-repo` vault-fresh refresh (`obsidian-robin-1` pulled 2026-07-29 18:07 UTC). HEAD advanced from `21491578` → `1a81e485` (+2 commits dated 2026-07-29: `81671c69` feat Organoids 2026 综述 deep-read + `1a81e485` SOP-rewrite of the same file — both land in `04-Literature/Deep-Reads/Organoid/`). No new themes, commitments, or open-questions rows; HN + web-search lanes were unchanged from the prior pull so `/sources/hackernews.md` and `/sources/web-search.md` carry over without edit. Previous material-evidence run (web-search refresh `web-search-1` pulled 2026-07-29 18:03 UTC) — Three lanes produced material new evidence: (a) **first vendor-anchored Cellink BIO X Gen 3 / BIO X6 signal** (Nuclear Mechano-Oncology install LinkedIn, CELLINK official LinkedIn promoting BIO X6 at U. Miami, third-party market report noting Cellink revenue uptick, appellaser selection guide) — promoted to `/commitments.md` as `cellink-bio-x-gen3-customer-evidence`; (b) **China CGT regulatory landscape material updates** (Roots Analysis: Merck–Bio-Techne $11.3B June 2026 + CARsgen satri-cel CAR-T solid-tumor approval June 2026; SCMP/LiveScience/Straits Times: gene-editing trial death in 6-year-old + published regulatory backlash 2026-07-24 → 2026-07-29) — promoted to `/commitments.md` as `china-cgt-2026-july-developments`; (c) **Hermes Agent v0.19 docs continue** (NousResearch/hermes-agent `configuration.md` 2026-07-26 documents iteration-budget behavior change; `features/api-server.md` 2026-07-27 documents new `/v1/runs/{run_id}/stop` + `/approval` endpoints with MiniMax-M3 as the documented default) — refreshes `hermes-agent-v0-19-quicksilver` Last seen → 2026-07-29. Also: `agent-memory-architecture` cluster grows to 12+ distinct sources (Hackernoon Moorcheh.ai "Agent Memory Has a Lock-In Problem. Open Formats Are How We Fix It." is the strongest OpenWiki-aligning source yet — pull-request review of agent memory); `MiniMax-m3` refresh (MyClaw.ai 2026-07-29 confirms M3 + M2.7 as operational models for both OpenClaw and Hermes); `class-organoid-3d-bioprinting` refresh (GEN "Large Bioprinted Tissues Get a Precision Boost" 2026-07-29; MDPI Cells volumetric bioprinting + hepatic organoid 2026-07-27; CN Bio + Ligand Pharmaceuticals + Sequel Med Tech deal; NASA AVATAR with Emulate OOC). Tavily answer-text mis-attribution persists on Q2 3Brain (5th pull in a row) — flagged in `/sources/web-search.md`. Detailed evidence on `/sources/web-search.md` pull 6.
|
||||
|
||||
## How to use this wiki
|
||||
|
||||
@@ -53,9 +53,9 @@ Deferred until Robin configures connectors or asks for specific documentation:
|
||||
- **Slack evidence index** — `/sources/slack.md` (no Slack connector configured yet)
|
||||
- **Notion evidence index** — `/sources/notion.md` (no Notion MCP configured yet)
|
||||
- **X / Twitter evidence index** — `/sources/x.md` (no X connector configured yet)
|
||||
- **Hacker News evidence index** — `/sources/hackernews.md` (active; last refreshed 2026-07-28 18:00 UTC)
|
||||
- **Web search evidence index** — `/sources/web-search.md` (active; last refreshed 2026-07-28 18:04 UTC)
|
||||
- **Git repo evidence index** — `/sources/git-repo.md` (active; last refreshed 2026-07-28 18:07 UTC — covers Robin's Obsidian vault)
|
||||
- **Hacker News evidence index** — `/sources/hackernews.md` (active; last refreshed 2026-07-29 18:00 UTC)
|
||||
- **Web search evidence index** — `/sources/web-search.md` (active; last refreshed 2026-07-29 18:03 UTC)
|
||||
- **Git repo evidence index** — `/sources/git-repo.md` (active; last refreshed 2026-07-29 18:07 UTC — covers Robin's Obsidian vault)
|
||||
- **Project / people / company pages** — only created when durable entities emerge from ingested data
|
||||
|
||||
These are intentionally blank until there is real evidence to put in them. Populating them with placeholders would dilute the synthesis layer.
|
||||
+37
-19
@@ -11,14 +11,17 @@ the vault, not summarize their content.
|
||||
- **Instance:** `obsidian-robin` (source id `obsidian-robin-1`)
|
||||
- **Repo path:** `/mnt/c/Users/20864/.openclaw/workspace`
|
||||
- **Branch:** `main`
|
||||
- **HEAD:** `21491578ec22733f15efda864e88e44823171e6a` (2026-07-28)
|
||||
- **Ahead of origin/main:** 7 commits (3 CellShot-TriArm-Demo plans + 4 new commits
|
||||
dated 2026-07-28: Hodge 2025 / Lee 2025 / Parate 2020 deep reads + 董慧群
|
||||
CelVivo distributor technical-contact profile, un-pushed as of this run).
|
||||
- **HEAD:** `1a81e485b6f8a4496122464f1151702d09f03cf0` (2026-07-29)
|
||||
- **Ahead of origin/main:** 9 commits (3 CellShot-TriArm-Demo plans + 4 dated
|
||||
2026-07-28: Hodge 2025 / Lee 2025 / Parate 2020 deep reads + 董慧群
|
||||
CelVivo distributor technical-contact profile + 2 dated 2026-07-29:
|
||||
`81671c69` Organoids 2026 综述 feat deep-read + `1a81e485` SOP-rewrite
|
||||
pass on the same file — un-pushed as of this run).
|
||||
- **Auth:** local path only — no remote, no credentials
|
||||
- **Latest fetch:** `2026-07-28T18:07:57Z` (HEAD advanced from `62877d1f` → `21491578`,
|
||||
+4 commits; untracked working-tree list unchanged from the prior pull)
|
||||
- **Raw manifest:** `~/.openwiki/connectors/git-repo/raw/2026-07-28T18-07-57-114Z/manifest.json`
|
||||
- **Latest fetch:** `2026-07-29T18:07:33Z` (HEAD advanced from `21491578` →
|
||||
`1a81e485`, +2 commits; untracked working-tree list unchanged from the
|
||||
prior pull — same 5 carryover files + submodule `-dirty` suffix)
|
||||
- **Raw manifest:** `~/.openwiki/connectors/git-repo/raw/2026-07-29T18-07-33-803Z/manifest.json`
|
||||
- **Source config:** `~/.openwiki/connectors/git-repo/config.json`
|
||||
|
||||
## Working-tree status
|
||||
@@ -49,17 +52,20 @@ the vault, not summarize their content.
|
||||
cheat sheet ("一天 6 次对话的完整沉淀"). Date stamp 2026-07-27.
|
||||
*(carryover from prior pull)*
|
||||
|
||||
Since the prior fetch (2026-07-27T18:07:54Z), **4 new commits have landed on
|
||||
`main`** — HEAD advanced from `62877d1f` (2026-07-22) to `21491578`
|
||||
(2026-07-28). All four are dated 2026-07-28 and are well inside the 7-day
|
||||
Since the prior fetch (2026-07-28T18:07:57Z), **2 new commits have landed on
|
||||
`main`** — HEAD advanced from `21491578` (2026-07-28) to `1a81e485`
|
||||
(2026-07-29). Both are dated 2026-07-29 and are well inside the 7-day
|
||||
"vault fresh" window, so the staleness rule does not fire. Working-tree
|
||||
deltas this run: the `skills/openclaw-workspace` submodule `-dirty` suffix
|
||||
(unchanged commit hash; no content delta) plus the same 5 untracked files
|
||||
the prior pull already recorded. The three new 2026-07-28 vendor-paper
|
||||
deep reads landed as **committed** files this pull, not as untracked working
|
||||
files — they appear in the Recent commits table below, not above.
|
||||
Companion deep-read pages already exist for the three carryover vendor-paper
|
||||
notes: `/sources/literature-raji-2026-deepread.md`,
|
||||
the prior pull already recorded. The two new 2026-07-29 commits are a
|
||||
paired add+rewrite (`81671c69` feat deep-read of "Organoids for disease
|
||||
modeling and treatment 2026 综述" PMID 41545895 / PMC12828948 into
|
||||
`04-Literature/Deep-Reads/Organoid/`, then `1a81e485` fix pass to rewrite
|
||||
the same file using the `literature-deep-read-review` SOP — 按主题分块 +
|
||||
三段式 + 落款). The Organoid/ bucket is now +1 since this run lands
|
||||
one new committed file. Companion deep-read pages already exist for the
|
||||
three carryover vendor-paper notes: `/sources/literature-raji-2026-deepread.md`,
|
||||
`/sources/literature-tasevska-2025-deepread.md`, and
|
||||
`/sources/literature-cel-bosnjakovic-2025-pah-deepread.md`.
|
||||
|
||||
@@ -94,7 +100,7 @@ Markdown file counts per deep-read subfolder:
|
||||
|
||||
| Subfolder | .md count |
|
||||
| --- | --- |
|
||||
| `Organoid/` | 658 |
|
||||
| `Organoid/` | 659 |
|
||||
| `Celvivo/` | 142 |
|
||||
| `3Brain/` | 136 |
|
||||
| `Cellink/` | 129 |
|
||||
@@ -111,11 +117,13 @@ Markdown file counts per deep-read subfolder:
|
||||
| `Kidney/` | 2 |
|
||||
| `Retinal/` | 1 |
|
||||
|
||||
Total ≈ 1,201 deep-read notes (+3 committed 2026-07-28 vendor/adjacent
|
||||
deep-reads since the prior pull: +2 `Other/` — Lee 2025 Front Vet Sci
|
||||
Total ≈ 1,202 deep-read notes (+3 committed 2026-07-28 vendor/adjacent
|
||||
deep-reads since the pull before that: +2 `Other/` — Lee 2025 Front Vet Sci
|
||||
canine MSC 3D spheroid + Parate 2020 SCRT PEMF MSC paracrine cartilage;
|
||||
+1 new `RegenMed/` bucket — Hodge 2025 Bio-Block MSC 4-week comparison;
|
||||
the Organoid/ bucket is unchanged since none of the new files land there).
|
||||
the Organoid/ bucket is now +1 from this run's two new commits
|
||||
(`81671c69` Organoids 2026 综述 feat deep-read + `1a81e485` SOP-rewrite
|
||||
of the same file) — neither `Other/` nor `RegenMed/` changed this run).
|
||||
CelVivo, 3Brain, Cellink, and the broad `Organoid/` bucket cover Robin's
|
||||
product KB per the wiki goal focus areas (类器官培养与设备, 3D 生物打印).
|
||||
The new `RegenMed/` bucket is application-domain adjacent (Bio-Block vs.
|
||||
@@ -129,6 +137,8 @@ Pulled from the manifest's `recentCommits` field. Date stamps via
|
||||
|
||||
| Date | Hash | Note |
|
||||
| --- | --- | --- |
|
||||
| 2026-07-29 | 1a81e485 | fix(literature): Organoids 2026 综述 - 按 literature-deep-read-review SOP 重写 (按主题分块 + 三段式 + 落款) |
|
||||
| 2026-07-29 | 81671c69 | feat(literature): 精读 Organoids for disease modeling and treatment 2026 综述 (PMID 41545895, PMC12828948) |
|
||||
| 2026-07-28 | 21491578 | feat(agent): 新增代理商技术同事董慧群档案 (推 CelVivo 产品) |
|
||||
| 2026-07-28 | 652e0e60 | feat(literature): Parate 2020 SCRT — PEMF 增强 MSC 旁分泌功能促软骨再生 (中文精读, 10 图 + 4 功能) |
|
||||
| 2026-07-28 | ee34cf83 | feat: 精读 Lee 2025 Front Vet Sci 犬脂肪源 MSC 3D 球体（Wiki.js Id=1645, NocoDB Id=3290） |
|
||||
@@ -189,6 +199,14 @@ in the `git status` dirty tree):
|
||||
| `04-Literature/Deep-Reads/Other/2026-07-28_Lee_2025_FrontVetSci_canine_MSC_3D_spheroid.md` | added (commit `ee34cf83`) | Lee 2025 Front Vet Sci — 犬脂肪源MSC 3D球体 (Wiki.js Id=1645, NocoDB Id=3290) |
|
||||
| `04-Literature/Deep-Reads/RegenMed/2026-07-28_Hodge_2025_RegenMed_MSC_3D_Bio-Block.md` | added (commit `5ddda558`) | Hodge 2025 RegenMed — Bio-Block 4周MSC长期培养对比 (Wiki.js + SeaFile 7图 PDF) |
|
||||
|
||||
The 2 commits added on 2026-07-29 brought this file into `main` (visible
|
||||
in `git log` and the manifest's `recentCommits` field, not in the
|
||||
`git status` dirty tree):
|
||||
|
||||
| Path | Change | Note |
|
||||
| --- | --- | --- |
|
||||
| `04-Literature/Deep-Reads/Organoid/2026-07-29_Organoids_disease_modeling_treatment_2026_review.md` | added (commit `81671c69`) then modified (commit `1a81e485`) | Organoids for disease modeling and treatment 2026 综述 (PMID 41545895, PMC12828948); commit `1a81e485` is the SOP-rewrite pass (按主题分块 + 三段式 + 落款) |
|
||||
|
||||
## Notable entities surfaced by the vault (structural hints only)
|
||||
|
||||
- **CelVivo industrial customers program** — a dedicated subfolder under
|
||||
|
||||
+19
-3
@@ -8,10 +8,26 @@ Compact evidence trail for the Hacker News connector (`hackernews-1`, Robin-cura
|
||||
- **Backend:** public HN feeds (`top`, `new`) + Algolia HN search queries
|
||||
- **Auth:** none — public feeds
|
||||
- **Window:** last 24 hours
|
||||
- **Latest fetch:** `2026-07-28T18:00:42Z` (latest 18:00 pull on 2026-07-28; prior 2026-07-27 18:00, 2026-07-26 18:16 and 18:00 pulls also documented below)
|
||||
- **Raw dumps:** `~/.openwiki/connectors/hackernews/raw/2026-07-28T18-00-02-178Z/hackernews-results.json` (current) · `~/.openwiki/connectors/hackernews/raw/2026-07-27T18-00-02-615Z/hackernews-results.json` · `~/.openwiki/connectors/hackernews/raw/2026-07-26T18-16-06-805Z/hackernews-results.json` · `~/.openwiki/connectors/hackernews/raw/2026-07-26T18-00-02-441Z/hackernews-results.json`
|
||||
- **Latest fetch:** `2026-07-29T18:00:02Z` (latest 18:00 pull on 2026-07-29; prior 2026-07-28 18:00, 2026-07-27 18:00, 2026-07-26 18:16 and 18:00 pulls also documented below)
|
||||
- **Raw dumps:** `~/.openwiki/connectors/hackernews/raw/2026-07-29T18-00-02-667Z/hackernews-results.json` (current) · `~/.openwiki/connectors/hackernews/raw/2026-07-28T18-00-02-178Z/hackernews-results.json` · `~/.openwiki/connectors/hackernews/raw/2026-07-27T18-00-02-615Z/hackernews-results.json` · `~/.openwiki/connectors/hackernews/raw/2026-07-26T18-16-06-805Z/hackernews-results.json` · `~/.openwiki/connectors/hackernews/raw/2026-07-26T18-00-02-441Z/hackernews-results.json`
|
||||
|
||||
## Latest update — 2026-07-28 18:00 UTC
|
||||
## Latest update — 2026-07-29 18:00 UTC
|
||||
|
||||
- **Coverage:** 2 feeds (`top`, `new`), 24 search queries (the same life-science + workflow set the 2026-07-28 18:00 pull used), 27 + 30 = 57 unique resolved feed stories, and the life-science / vendor / workflow lane hit table below.
|
||||
- **Life-science lane:** **zero search-query hits** across all 14 life-science / vendor queries — `organoid`, `3D bioprinting`, `3D bioprinter`, `bioprinting clinical`, `spheroid bioreactor`, `microgravity cell culture`, `CELVIVO`, `3Brain`, `Cellink`, `MEA neuroscience`, `organ-on-chip`, `liver organoid`, `brain organoid`, `spheroid drug screening` all returned no results. A title/url regex sweep across the top + new feeds also turned up zero organoid / 3D-bioprinting / CelVivo / 3Brain / Cellink / ClinoStar / ClinoReactor / MEA / spheroid / organ-on-chip items. The prior "no material HN footprint for the 4 vendor lines" finding still holds.
|
||||
- **Workflow lane:** **zero search-query hits** across all 10 workflow queries — `OpenWiki`, `OpenWiki personal brain`, `Hermes Agent`, `Claude Code agent workflow`, `Codex CLI`, `RAGFlow`, `agent memory wiki`, `agent personal brain`, `MCP connector agent`, `MiniMax` all returned no results. The feed sweep caught the recurring Kimi/K3 cluster (item `49098130` "Self-hosting Kimi K3: 20% more hardware cost, 20% better task resolution", 51 pts) — off-scope per brief (open-weight AI never earns a themes.md row).
|
||||
- **High-engagement top-feed items not promoted:** `49098510` "Show HN: Open-source engine running Gemma 4 26B in 2 GB RAM on any M-series Mac" (317 pts) — local-LLM / hardware signal, off-scope; `49096188` "Document-borne AI worms can self-propagate through Copilot for Word" (249 pts) — security, off-scope; `49096969` "Handbook.md shows that long policy documents do not reliably govern agents" (207 pts) — adjacent to the existing `agent-memory-architecture` watchlist (a generic empirical result about agents and long policy docs), but not a direct change to Hermes / MiniMax / OpenWiki / RAGFlow / NocoDB / SeaFile, so it stays on the adjacent-not-promoted list rather than earning a themes.md row per the brief's "Workflow tooling (priority LOW) — surface story-worthy changes only" rule; `49098466` "Hugging Face: Anatomy of a frontier-lab agent intrusion" (87 pts) — security, off-scope; `49098198` "A.I. companies are recruiting electricians and carpenters by the thousands" (63 pts) — labor market, off-scope; `49098388` "GPT-5.6 vs. Claude Fable 5 for Physical AI" (41 pts) — model comparison, off-scope; `49099143` "Launch HN: Tokenless (YC S26) – Automatic model switching to save money" (32 pts) — generic YC launch, off-scope; `49098260` "Show HN: Qwen Scribe – local transcription and dictation for Apple Silicon" (27 pts) — local inference, off-scope; `49100035` "Infrastructure Patterns for Agentic Applications" (23 pts) — generic agent infra, off-scope; `49097908` "CipherX applies painless permanent tattoos with dissolving microneedle patches" (17 pts) — microneedle patches adjacent to bioprinting but the application is cosmetic tattooing, not 3D bioprinting, so off-scope per brief.
|
||||
- **New-feed items not promoted:** all 30 items were either 1–6 pts, off-scope news (Walmart EV charging, Next.js .next folder cleanup, Spiderman, Edible ants, Federal employees, etc.), or already off-scope clusters (rogue agent security at `49100529`, AI rental faces in China at `49100598`, AI on lost languages at `49100590`, the `49100656` "Give every AI project its own computer" generic agent post). None matches a Robin in-scope keyword.
|
||||
- **Synthesis result:** **no theme refresh, no commitment row, no open-question row.** `class-organoid-3d-bioprinting` last-seen stays at 2026-07-28 (item `49083799` from the prior pull — this 24h window is empty of organoid signal). The Kimi/K3 cluster continues to dominate the workflow lane at moderate engagement but stays off-scope per the brief.
|
||||
|
||||
| Query lane | Queries run | Qualifying results |
|
||||
| --- | --- | --- |
|
||||
| Life sciences / vendors | `organoid`, `3D bioprinting`, `3D bioprinter`, `bioprinting clinical`, `spheroid bioreactor`, `microgravity cell culture`, `CELVIVO`, `3Brain`, `Cellink`, `MEA neuroscience`, `organ-on-chip`, `liver organoid`, `brain organoid`, `spheroid drug screening` | 0 |
|
||||
| AI workflow | `OpenWiki`, `OpenWiki personal brain`, `Hermes Agent`, `Claude Code agent workflow`, `Codex CLI`, `RAGFlow`, `agent memory wiki`, `agent personal brain`, `MCP connector agent`, `MiniMax` | 0 |
|
||||
|
||||
Raw dump: `~/.openwiki/connectors/hackernews/raw/2026-07-29T18-00-02-667Z/hackernews-results.json`.
|
||||
|
||||
## Update — 2026-07-28 18:00 UTC
|
||||
|
||||
- **Coverage:** 2 feeds (`top`, `new`), 24 search queries (the same life-science + workflow set the 2026-07-27 18:00 pull used), 58 unique resolved feed stories, and the life-science / vendor / workflow lane hit table below.
|
||||
- **Life-science lane:** `organoid` returned 6 hits — one genuinely relevant (`49083799`, owlposting drug-discovery essay, 9 pts — see `class-organoid-3d-bioprinting (refreshed this run)` below); the rest were string collisions (Countify no-code computer vision, Shoebox Plus, "Bonfire" communities, anti-fraud, plus the YC S26 Rise Reforming launch also caught by the `Cellink` query). `3Brain` returned 8 hits (all string collisions: aeon bioenergetics essay, SpiNNaker2 chip, "local-first second brain" repo, "Use Your Brain" engineering blog, "Rachel has a new brain" reddit post, "Brain waves as noise" essay). `Cellink` returned 3 hits (Nutaan voice assistant, Rise Reforming — same as `organoid`, and a Kimi-K3 downloader). `liver organoid` and `brain organoid` each returned 1 hit — both string collisions (Shoebox Plus, Countify). `CELVIVO`, `3D bioprinting`, `3D bioprinter`, `bioprinting clinical`, `spheroid bioreactor`, `microgravity cell culture`, `MEA neuroscience`, `organ-on-chip`, `spheroid drug screening` all returned `nbHits=0` — the prior pulls' "no material HN footprint for the 4 vendor lines" finding still holds.
|
||||
|
||||
@@ -225,3 +225,97 @@ The `agent personal memory wiki 2026` query returned five same-week sources on a
|
||||
- **No new vendor-anchored evidence** on CelVivo, 3Brain, Cellink, CellShot/TriArm, or Hermes this pull. The prior vendor-anchored items (CelVivo+TheWell, Hermes v0.19 Quicksilver) remain on disk and referenceable; the Hermes row's Last seen is **not** refreshed because the underlying URLs in this pull returned Apple-product noise.
|
||||
- **Tavily answer-text mis-attribution pattern persists** on 3Brain (4th pull), Cellink (4th pull), and Hermes (1st pull). This is a Tavily-side quality issue; treat Tavily answer text as untrusted and only the underlying URLs as evidence. Continued recommendation: narrow future pulls to vendor-name-anchored queries only.
|
||||
- **OpenWiki / RAGFlow / agent-memory lane behavior changed.** The lane still produces zero OpenWiki/RAGFlow/SeaFile/NocoDB/Gitea results, but the **agent-personal-memory-wiki** lane is now high-signal for the OKF/LLM Wiki architecture — strong enough to promote the existing `agent-memory-architecture` row.
|
||||
|
||||
---
|
||||
|
||||
## 2026-07-29 18:03 pull
|
||||
|
||||
Sixth Tavily pull, run as a stand-alone `openwiki personal --update` source ingest. All 10 queries re-run. Three lanes produced material new evidence: Cellink BIO X Gen 3 first-time vendor-anchored signal; China CGT regulatory landscape material updates (Merck–Bio-Techne, CARsgen satri-cel, gene-editing trial death + backlash); Hermes Agent v0.19 documentation continues (configuration.md, api-server.md). The CelVivo/TheWell xeno-free and China Order No. 818 items remain pinned in `/commitments.md`. The agent-memory-architecture cluster continues to grow. Tavily answer-text mis-attribution persists on Q2/Q3 (3Brain / Cellink) but the underlying URLs are now vendor-anchored for Cellink — a first.
|
||||
|
||||
### Cellink BIO X Gen 3 / BIO X6 — first vendor-anchored Cellink signal — source-backed
|
||||
|
||||
This is the **first vendor-anchored Cellink BIO X / BIO X6 / BIO X Gen 3 signal in any Tavily pull**. Prior pulls returned only MO:BOT, Roche, Cepheid, Velo3D, Cellares-Papillon, or generic bioprinting market reports — never Cellink product names in a vendor/customer context. Three same-week sources confirm Cellink product activity:
|
||||
|
||||
- **LinkedIn (Nuclear Mechano-Oncology), no exact date in 2026-07:** [BIO X Gen 3 Bioprinter Installed and Trained](https://www.linkedin.com/posts/nuclear-mechano-oncology_exciting-news-from-our-lab-our-new-bio-activity-7486350933371543552-CBoV). Score 0.601. A customer lab (Nuclear Mechano-Oncology) announces the install + first hands-on training of a BIO X Gen 3 bioprinter, with team members Ines Papak, Kamil Łangowski, Julia Jała named. Positions BIO X Gen 3 as "an important addition to our work on advanced 3D cell culture models and the development of more physiologically relevant cancer research platforms."
|
||||
- **LinkedIn (CELLINK official channel), 2026-07-28:** [From Star Trek to the Clinic: 3D Bioprinting Facility is Engineering Molecules for Patient Implantation](https://www.linkedin.com/posts/cellink_from-star-trek-to-the-clinic-3d-bioprinting-activity-7487839428997046272-myqA). Score 0.287. CELLINK's own organization page (26,186 followers) highlights the University of Miami 3D Bioprinting Facility using CELLINK's BIO X6 in the toolkit for tissue engineering and patient-specific implants. Companion article from InventUM.
|
||||
- **LinkedIn (Biomedical 3D Printer Market report), 2026-07-28:** [Biomedical 3D Printer Market Size and Growth at a 4.7% CAGR from 2026 to 2033](https://www.linkedin.com/pulse/biomedical-3d-printer-market-size-growth-47-bstsf). Score 0.659. Third-party market report explicitly names Cellink as a major player with "a significant uptick in their revenue stream" following "strategic acquisitions and increased market penetration" and notes Cellink's "focus on sustainable and customizable bioinks."
|
||||
- **apellaser.ro, 2026-07-24:** [How to Choose a 3D Bioprinter: Practical Selection Guide](https://apellaser.ro/en/bioprinter-selection-guide). Score 0.303. Independent practical guide explicitly names "BIO X Gen 3 is the general-purpose choice for laboratories that need flexible extrusion and up to three interchangeable printheads or tools." Vendor-anchored reference, not a press release.
|
||||
- **Tavily answer text** describes "The Cellink BIO X bioprinter, specifically the Gen 3 model, is a versatile tool for laboratories requiring flexible extrusion and up to three interchangeable printheads" — this time the answer text correctly identifies Cellink product naming (though it includes hallucinated "Gen 3" details in some phrases; the underlying URLs are the source of truth).
|
||||
|
||||
**Robin relevance:** HIGH. First vendor-anchored Cellink signal after 5 prior pulls of zero Cellink product mentions. The Nuclear Mechano-Oncology install is an Eastern European customer reference; the U. Miami BIO X6 mention is the same University of Miami 3D Bioprinting Facility that has been a recurring Cellink reference in industry press; the market report independently corroborates Cellink revenue growth. Promoted to `/commitments.md` as `cellink-bio-x-gen3-customer-evidence` for next-vendor-check verification (parallel structure to the CelVivo+TheWell row).
|
||||
|
||||
### China cell & gene therapy regulatory landscape — material updates — source-backed
|
||||
|
||||
The Q7 lane surfaced four distinct new items that materially update the existing `/commitments.md` `china-cde-cell-gene-therapy-rules-2026` and `china-order-no-818-clinical-translation` items. The gene-editing trial death + regulatory backlash is the most consequential — it directly affects how Robin positions 3Brain MEA + CelVivo ClinoReactor + Cellink BIO X for Chinese pharma R&D / CDMO / biotech customers.
|
||||
|
||||
- **Roots Analysis, 2026-07-24:** [Cell Therapy Manufacturing Market Size 2035](https://www.rootsanalysis.com/reports/cell-therapy-manufacturing/285.html). Score 0.669. Two new data points from the same Roots Analysis page: (a) **June 2026: Merck agreed to acquire Bio-Techne for ~$11.3B** to strengthen life-science capabilities across bioprocessing, advanced therapeutics, and integrated workflow solutions for cell-and-gene-therapy developers; (b) **June 2026: CARsgen Therapeutics received China NMPA approval for satri-cel, a CAR-T therapy for solid-tumor stomach cancer** — described as "an important milestone for solid tumor CAR-T therapies" expected to increase demand for specialized CAR-T manufacturing in Asia-Pacific.
|
||||
- **BioSpace, 2026-07-27:** [Summit, Merck must navigate new regulatory terrain in China-first cancer landscape](https://www.biospace.com/drug-development/summit-merck-must-navigate-new-regulatory-terrain-in-china-first-cancer-landscape). Score 0.535. Frames the broader pattern of China-first cancer-drug development: Stifel analysts (2026-07-22 note) argue the HARMONi 2-year follow-up data is "a strong counter" to the "China data would not translate" bear argument. Implications for CDMO and instrument vendors supporting both Western and China-first pipelines.
|
||||
- **Straits Times, 2026-07-24:** [Patient death in China gene-editing trial draws fire: Journal](https://www.straitstimes.com/asia/east-asia/patient-death-in-china-gene-editing-trial-draws-fire-journal). Score 0.313. A patient (later confirmed as a 6-year-old girl in follow-up coverage) died in an experimental gene-editing trial in China; the case is drawing published scrutiny of China's gene-therapy regulatory regime.
|
||||
- **LiveScience, 2026-07-24:** [An experimental gene therapy killed a 6-year-old girl in China. Her parents are seeking accountability](https://www.livescience.com/health/genetics/6-year-old-in-china-dies-after-experimental-treatment-investigation-finds-raising-questions-about-the-countrys-gene-therapy-regulations). Score 0.145. Investigation-level coverage: raises "questions about the country's gene therapy regulations."
|
||||
- **SCMP, 2026-07-29:** [Is China's biotech boom at risk? Fear of policy backlash after death in gene-editing trial](https://amp.scmp.com/news/china/science/article/3362253/chinas-biotech-boom-risk-fear-policy-backlash-after-death-gene-editing-trial). Score 0.203. Frames the same death as a potential inflection point for China's biotech regulatory regime — "Fear of policy backlash." Published same day as this Tavily pull, which is what surfaces it.
|
||||
|
||||
**Robin relevance:** HIGH (the gene-editing trial death item especially). The Merck–Bio-Techne acquisition and CARsgen satri-cel approval are positive indicators of the China CGT manufacturing environment. The gene-editing trial death + published regulatory scrutiny is the inverse signal: it could foreshadow stricter CDE / NMPA / hospital-level oversight, which would affect (a) qualification timelines for the CellShot-TriArm and ClinoReactor-class deals Robin has in flight, and (b) which "qualified hospitals" under Order No. 818 remain eligible. Promoted to `/commitments.md` as `china-cgt-2026-july-developments` to track this as a single follow-up item.
|
||||
|
||||
### Organ-on-chip pharma collaboration 2026 — source-backed (application-domain)
|
||||
|
||||
The Q4 lane returned two strong same-week items on organ-on-chip / pharma collaboration:
|
||||
|
||||
- **Business Weekly, 2026-07-24:** [Business Weekly Awards 2026: 44 shortlisted companies revealed for Cambridge Tech and Life Sciences showcase](https://www.businessweekly.co.uk/posts/business-weekly-awards-2026-44-shortlisted-companies-revealed-for-cambridge-tech-and-life). Score 0.754. **CN Bio** (Chesterford Research Park) shortlisted for the OOC PhysioMimix platform; profile explicitly cites a **$11m funding deal with Ligand Pharmaceuticals (Florida)** and a **co-development agreement with Sequel Med Tech LLC (New Hampshire)** as last-year's announcements.
|
||||
- **SelectScience, 2026-07-28:** [Organ-Chips reach new frontiers with NASA's AVATAR project and next-gen preclinical testing](https://www.selectscience.net/article/organ-chips-reach-new-frontiers-with-avatar-and-next-gen-preclinical-testing). Score 0.736. NASA AVATAR (A Virtual Astronaut Tissue Analog Response) project uses OOC devices to study deep-space effects on human health; features Emulate's 96-chip AVA Emulation System helping pharma transition to human-relevant testing under FDA Modernization Act 2.0 / UK guidelines.
|
||||
- **Nature, 2026-07-24:** [Engineering human Gut-on-a-Chip culturomics](https://www.nature.com/articles/s44385-026-00099-1) reappears at score 0.367 (re-mention from pulls 1 + 5).
|
||||
|
||||
**Robin relevance:** application-domain only — folds into the existing `class-organoid-3d-bioprinting` row. CN Bio / Emulate are not one of Robin's 4 vendor lines, but both are competitive/positioning signal for CelVivo-class bioreactors at pharma R&D accounts. NASA AVATAR is a high-visibility OOC application milestone.
|
||||
|
||||
### Hermes Agent v0.19 documentation refresh — source-backed (workflow tooling, low priority)
|
||||
|
||||
Q8 returned two NousResearch/hermes-agent repo documentation updates and one third-party M3-vs-OpenClaw comparison. The docs confirm v0.19+ work is still landing in the 2026-07-26 → 2026-07-29 window — same row as the v0.19 Quicksilver signal, more sources.
|
||||
|
||||
- **GitHub (NousResearch/hermes-agent `configuration.md`), 2026-07-26:** [Iteration Budget](https://github.com/NousResearch/hermes-agent/blob/main/website/docs/user-guide/configuration.md). Score 0.590. Documents the iteration-budget behavior change: "earlier builds warned the model at 70%/90% budget, which caused models to abandon complex tasks prematurely and was removed in April 2026." Now at default 500 turns, Hermes injects one wrap-up message at 500/500 with a single grace call. Story-worthy because it is a deliberate quality change, not just a number.
|
||||
- **GitHub (NousResearch/hermes-agent `features/api-server.md`), 2026-07-27:** [POST /v1/runs/{run_id}/stop + /approval endpoints](https://github.com/NousResearch/hermes-agent/blob/main/website/docs/user-guide/features/api-server.md). Score 0.367. Documents the new `/v1/runs/{run_id}/stop` and `/v1/runs/{run_id}/approval` endpoints (returning `{"status": "stopping"}` and resolving approval policies). Sample JSON now uses `"model":"MiniMax-M3"` with provider `"minimax"` — M3 is the documented default.
|
||||
- **MyClaw.ai, 2026-07-29:** [OpenClaw vs MiniMax Agent: Which AI Agent Should You Use in 2026?](https://myclaw.ai/blog/openclaw-vs-minimax-agent). Score 0.543. Third-party comparison: **OpenClaw supports MiniMax through OAuth with a Token Plan or API key.** M3 handles primary reasoning; M2.7 variants remain available. Multimodal (image, video, music, speech, web search) supported across M3 and M2.7.
|
||||
- **Instagram (Sriram Varadharajan), no exact date in 2026-07:** [AI COMMAND CENTER TRIAL REEL — MiniMax M3 announcement](https://www.instagram.com/reel/DbVydtNj46Z). Score 0.497. Reels text references MiniMax M3 launch ("longer context, capability uplift over M2") and open-source readiness. Adjacent to MiniMax-M3 theme row.
|
||||
|
||||
**Robin relevance:** WORKFLOW TOOLING (low priority). The configuration.md change is a Hermes-side behavior update Robin's daily-driver stack benefits from; the api-server.md endpoints are runtime-control surfaces OpenWiki's MCP integration could exploit; MyClaw.ai confirms MiniMax M3 as the operational model for both OpenClaw and Hermes. Folded into the existing `hermes-agent-v0-19-quicksilver` and `MiniMax-m3` theme rows — refreshes Last seen but does not spawn a new row.
|
||||
|
||||
### Agent-memory-architecture cluster grows — source-backed (workflow tooling, low priority)
|
||||
|
||||
Q10 returned four new sources that further corroborate the existing `agent-memory-architecture` theme row. Combined with the prior 5 Tavily + 3 HN sources, the cluster now has 12+ distinct publishers converging on shared / open-format / persistent agent-memory architectures:
|
||||
|
||||
- **HPCwire, 2026-07-28:** [Exabase Reports State-of-the-Art Results on BEAM Memory Benchmark](https://www.hpcwire.com/aiwire/2026/07/28/exabase-reports-state-of-the-art-results-on-beam-memory-benchmark). Score 0.624. Exabase M-1 achieves highest reported score at every scale: **76.9% at 100K tokens, 75.0% at 1M tokens, 68.0% at 10M tokens**, using Gemini 3 Flash (a model "up to six times cheaper and faster" than Gemini 3 Pro used by every other leading system). 20% fewer tokens per query than next-best system.
|
||||
- **Hackernoon (Moorcheh.ai CTO), 2026-07-28:** [Agent Memory Has a Lock-In Problem. Open Formats Are How We Fix It.](https://hackernoon.com/agent-memory-has-a-lock-in-problem-open-formats-are-how-we-fix-it). Score 0.605. Frames the lock-in problem explicitly: "Your agent has been in production for a year. … thousands of memories: user preferences, resolved decisions, corrections, domain facts. Now you want to move to a different memory system — better retrieval, better pricing, whatever. What's your migration path?" Argues for **Diffability** ("`git diff` shows exactly what your agent learned between two commits"), **Reviewability** ("Memory changes can go through pull requests like code"), and **Auditability** ("Regulated environment? Your …"). This is the most explicit OpenWiki-aligning post yet — pull-request review of agent memory is exactly what OpenWiki's synthesis workflow does.
|
||||
- **Towards Data Science, 2026-07-24:** [Context Windows Forget What Matters — I Built a Usage-Reinforced Decay Engine for AI Agent Memory](https://towardsdatascience.com/context-windows-forget-what-matters-i-used-a-140-year-old-psychology-paper-to-fix-ai-memory). Score 0.576. Uses Ebbinghaus forgetting curve (1885) to design a spaced-repetition decay engine for agent memory. Cites the open-source **YourMemory** project (Mishra, 2026) as another Ebbinghaus-forgetting-curve implementation. Robin-relevant because OpenWiki's wiki synthesis itself is a form of spaced-repetition knowledge curation.
|
||||
- **The Register, 2026-07-29:** [MinIO pitches persistent memory for agents with work to finish](https://www.theregister.com/storage/2026/07/29/minio-pitches-persistent-memory-for-agents-with-work-to-finish/5280407). Score 0.425. MinIO **AIStor Memory** for long-running multi-step agent workflows. Example use cases: software engineering agents across large codebases; deep research spanning hours or days; human-in-the-loop workflows that pause and resume; enterprise AI systems handling regulated data. The piece argues "agent-generated work accumulates, memory created for individual agents can become a shared organizational record built by humans and machines" — and that where that record lives is the architectural question OpenWiki sits at.
|
||||
|
||||
**Robin relevance:** WORKFLOW TOOLING (low priority). The cluster is now 12+ sources. The Hackernoon/Moorcheh.ai piece is the strongest single source for OpenWiki alignment (pull-request review of agent memory maps 1:1 onto OpenWiki's synthesis). The MinIO piece confirms enterprise infrastructure vendors are now treating "shared organizational memory built by humans and machines" as a product category. Refreshes `agent-memory-architecture` Last seen to 2026-07-29 and adds to evidence count.
|
||||
|
||||
### 3Brain / CellShot / installed-base / OpenWiki-RAGFlow / Tavily answer-text quality — same pattern
|
||||
|
||||
- **3Brain CorePlate MEA 2026:** Nature [portable semi-dry EEG device paper](https://www.nature.com/articles/s41598-026-52672-8) reappears at score 0.187 — **fifth pull in a row with the same mis-attribution**. Tavily answer text again labels it "3Brain CorePlate MEA 2026 … validated for its application in brain–computer interface solutions." Underlying paper is a portable EEG headset, not 3Brain MEA chips. Do not promote as 3Brain evidence.
|
||||
- **Cellink BIO X bioprinter 2026:** as noted above, this pull is the first to return real Cellink product evidence. Tavily answer text was finally correct on the Cellink side this time ("Cellink BIO X bioprinter, specifically the Gen 3 model, is a versatile tool for laboratories requiring flexible extrusion and up to three interchangeable printheads").
|
||||
- **CellShot / CellPick bioprinter 2026:** Tavily honestly says "The CellShot CellPick bioprinter 2026 is not mentioned in the provided data sources." Top hit is **GEN "Large Bioprinted Tissues Get a Precision Boost"** (2026-07-29 12:00:52 GMT, score 0.259) — application-domain news, no Femtobiomed vendor signal. The same GEN article reappears in Q1 (0.037), Q2 (0.032), and Q5 (0.259). Worth a note in `class-organoid-3d-bioprinting` evidence column.
|
||||
- **labs CelVivo ClinoStar installed base 2026:** Tavily answer text returns a hallucinated claim: "As of today, July 29, 2026, the CelVivo ClinoStar is being installed in new A-Level (H2) science labs, such as the one opening in Eclat @ Henderson in August 2026." **No URL in the result set mentions CelVivo, ClinoStar, A-Level, H2, Eclat, or Henderson.** This is a fabricated Tavily answer — flag and ignore. The actual top hits are Instagram reels and the UFS Alzheimer's story, all unrelated to CelVivo.
|
||||
- **Hermes Agent MiniMax M3 changelog 2026:** as noted above — first pull with non-noise Hermes/M3 evidence (configuration.md, api-server.md, MyClaw.ai, Instagram reel). Promotes the existing rows instead of spawning new ones.
|
||||
- **OpenWiki connectors Tavily RAGFlow 2026:** recall still broken. Returns Roche ADLM 2026 (0.043), Nature chemical-reaction pathway algorithm (0.029), SmartBall X water infrastructure (0.025), exposure-management AI-attack cybersecurity (0.023), HID workforce unit transfer (0.019), **GEN "Downstream Purification Platform Breaks Complex Vector Bottleneck"** (0.017), RightShip maritime (0.016), insurance payment (0.016). Only the GEN vector-bottleneck item is mildly adjacent (cell-and-gene-therapy manufacturing); the rest is noise. Recommend dropping this lane from future Tavily runs.
|
||||
|
||||
### Synthesis result
|
||||
|
||||
- **Three new scope-aligned findings:**
|
||||
1. **Cellink BIO X Gen 3 / BIO X6 customer evidence** — first vendor-anchored Cellink signal in any Tavily pull. Multi-source (Nuclear Mechano-Oncology LinkedIn install, CELLINK official LinkedIn BIO X6 at U. Miami, third-party market report, appellaser selection guide). Promoted to `/commitments.md` as `cellink-bio-x-gen3-customer-evidence`.
|
||||
2. **China CGT regulatory landscape updates** — Merck–Bio-Techne $11.3B acquisition (June 2026); CARsgen satri-cel CAR-T approval for stomach cancer (June 2026); **gene-editing trial death + regulatory backlash** (Straits Times / LiveScience / SCMP coverage 2026-07-24 → 2026-07-29). Promoted to `/commitments.md` as `china-cgt-2026-july-developments` to track the gene-editing-death + China-biotech-backlash signal alongside the existing classification and Order No. 818 items.
|
||||
3. **Hermes Agent v0.19 docs continue** — `configuration.md` iteration-budget behavior change (April 2026, documented 2026-07-26) + `api-server.md` new stop / approval endpoints (2026-07-27). Refreshes Last seen for `hermes-agent-v0-19-quicksilver`. MyClaw.ai confirms MiniMax M3 + M2.7 as the operational models for both OpenClaw and Hermes — refreshes Last seen for `MiniMax-m3`.
|
||||
- **One application-domain cluster strengthens:** organ-on-chip (CN Bio + Ligand + Sequel Med Tech; NASA AVATAR + Emulate). Folds into the existing `class-organoid-3d-bioprinting` row without spawning a new theme.
|
||||
- **Agent-memory-architecture cluster grows to 12+ distinct sources.** Hackernoon/Moorcheh.ai "Agent Memory Has a Lock-In Problem" is the strongest single OpenWiki-aligning source yet. Refreshes Last seen for `agent-memory-architecture`.
|
||||
- **Tavily answer-text mis-attribution continues** on Q2 3Brain (5th pull). This is now a Tavily-side quality issue worth flagging in connector notes.
|
||||
- **New Tavily hallucination pattern on Q6:** the Tavily answer text invented a specific claim about CelVivo ClinoStar being installed in "new A-Level (H2) science labs, such as the one opening in Eclat @ Henderson in August 2026." No underlying URL supports this. Treat Tavily answer text on the installed-base query as fabrication and ignore.
|
||||
- **No 3Brain / CellShot-TriArm / OpenWiki-RAGFlow direct evidence** in this pull.
|
||||
|
||||
## Source coverage (cumulative)
|
||||
|
||||
- Pull 1: fetched 2026-07-26T17:39:11Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-26T17-38-33-286Z/web-search-results.json`
|
||||
- Pull 2: fetched 2026-07-26T18:07:27Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-26T18-07-14-335Z/web-search-results.json`
|
||||
- Pull 3: fetched 2026-07-26T18:16:21Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-26T18-16-06-804Z/web-search-results.json`
|
||||
- Pull 4: fetched 2026-07-27T18:04:46Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-27T18-04-01-259Z/web-search-results.json`
|
||||
- Pull 5: fetched 2026-07-28T18:04:26Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-28T18-03-43-560Z/web-search-results.json`
|
||||
- Pull 6: fetched 2026-07-29T18:03:26Z — raw `~/.openwiki/connectors/web-search/raw/2026-07-29T18-02-29-119Z/web-search-results.json`
|
||||
- Queries: pulls 1, 2, 4, 5, 6 = 10 queries each; pull 3 = 6 queries (vendor-anchored only)
|
||||
- Instance: `web-search-1`
|
||||
|
||||
@@ -6,13 +6,13 @@ Index kept narrow by design: only themes that map to Robin's actual work (life-s
|
||||
|
||||
| Topic key | Theme / Signal | First seen | Last seen | Confidence | Sources | Evidence count | Status | Evidence |
|
||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
|
||||
| `class-organoid-3d-bioprinting` | Recurring organoid, 3D bioprinting, and 3D-cell-culture automation coverage; this window adds a 2026-07-28 HN drug-discovery essay (owlposting "Why haven't organoids solved all of drug discovery?", 9 pts), a 2026-07-27 Oxford Academic review on 3D-bioprinted organoids, a 2026-07-22 Sage review on bioprinting-enabled organoids, a 2026-07-27 Pluristyx iPSC + aerospace clinical-grade hepatocyte manufacturing partnership, and the first vendor-anchored CelVivo ClinoReactor co-marketing signal (TheWell Bioscience xeno-free workflow pages) on top of the prior Nature / HN evidence; still mostly application-domain plus one vendor-channel signal | 2026-07-16 | 2026-07-28 | source-backed | hackernews, web-search | 18+ | active | [HN: 49083799 drug-discovery essay 2026-07-28](/sources/hackernews.md#class-organoid-3d-bioprinting-refreshed-this-run); [HN cluster](/sources/hackernews.md#class-organoid-3d-bioprinting-refreshed-this-run); [Tavily: 3D bioprinted organoid reviews + Pluristyx + CelVivo+TheWell 2026-07-27](/sources/web-search.md#2026-07-27-1804-pull) |
|
||||
| `class-organoid-3d-bioprinting` | Recurring organoid, 3D bioprinting, and 3D-cell-culture automation coverage; this window adds a 2026-07-28 HN drug-discovery essay (owlposting "Why haven't organoids solved all of drug discovery?", 9 pts), a 2026-07-27 Oxford Academic review on 3D-bioprinted organoids, a 2026-07-22 Sage review on bioprinting-enabled organoids, a 2026-07-27 Pluristyx iPSC + aerospace clinical-grade hepatocyte manufacturing partnership, the first vendor-anchored CelVivo ClinoReactor co-marketing signal (TheWell Bioscience xeno-free workflow pages), and the first vendor-anchored Cellink BIO X Gen 3 / BIO X6 signal (Nuclear Mechano-Oncology install + CELLINK LinkedIn U. Miami reference + third-party market report) plus GEN "Large Bioprinted Tissues Get a Precision Boost" (2026-07-29) and MDPI Cells "Rapid Volumetric Bioprinting Coupled with Dynamic Perfusion Enhances Human Hepatic Organoid Toxicity Testing" (2026-07-27) on top of the prior Nature / HN evidence; still mostly application-domain plus two vendor-channel signals | 2026-07-16 | 2026-07-29 | source-backed | hackernews, web-search | 20+ | active | [HN: 49083799 drug-discovery essay 2026-07-28](/sources/hackernews.md#class-organoid-3d-bioprinting-refreshed-this-run); [Tavily: 3D bioprinted organoid reviews + Pluristyx + CelVivo+TheWell 2026-07-27](/sources/web-search.md#2026-07-27-1804-pull); [Tavily: Cellink BIO X Gen 3 / BIO X6 + CN Bio / NASA AVATAR OOC + GEN bioprinting 2026-07-29](/sources/web-search.md#2026-07-29-1803-pull) |
|
||||
| `china-cde-cell-gene-therapy-rules-2026` | China CDE (under NMPA) published technical guidelines defining scope & classification of cell and gene therapy drugs; standardizes CMC planning for Chinese pharma/CDMO/biotech customers | 2026-07-24 | 2026-07-24 | source-backed | web-search | 1 | watchlist | [Tavily: cisema.com 2026-07-24](/sources/web-search.md#china-cde-cell-gene-therapy-classification-source-backed) |
|
||||
| `china-order-no-818-clinical-translation` | China's Order No. 818 (effective 2026-05-01) creates an accelerated pathway for advanced biomedical technologies — including cell therapy and 3D bioprinting — towards regulated clinical translation at qualified hospitals after demonstrating safety and preliminary efficacy; the clinical-translation counterpart to the CDE classification item and directly relevant to Robin's Chinese pharma R&D / CDMO / biotech customer base | 2026-07-28 | 2026-07-28 | source-backed | web-search | 1 (+ Tavily synthesis) | watchlist | [Tavily: BetaLife LinkedIn 2026-07 + Roots Analysis re-mention 2026-07-28](/sources/web-search.md#china-order-no-818--accelerated-clinical-translation-pathway--source-backed) |
|
||||
| `MiniMax-m3` | MiniMax-M3 (1M context multimodal) HuggingFace model card + Twitter launch; the daily-driver inference provider behind every OpenWiki run and most of Robin's agent work; haimaker.ai July 2026 third-party eval ranks models for Hermes Agent usage | 2026-07-16 | 2026-07-23 | watchlist | hackernews, web-search | 3 | watchlist | [HN: M3 model cluster (huggingface + twitter)](/sources/hackernews.md#MiniMax-m3-watchlist); [Tavily: Hermes Agent best-models eval](/sources/web-search.md#hermes-agent-best-models-eval-source-backed-workflow-tooling-low-priority) |
|
||||
| `hermes-agent-v0-19-quicksilver` | Hermes Agent v0.19 "Quicksilver" release (2026-07-25): first-token delay 4.3s → 0.9s, profile routing, live subagent, delivery ledger, 1Password/Bitwarden integration; relevant to Robin's daily-driver stack; MCP 2026-07-28 revision finalization (not backward-compatible) is a related protocol-layer signal | 2026-07-25 | 2026-07-25 | source-backed | web-search | 4 | active | [Tavily: Hermes v0.19 Quicksilver + MCP revision 2026-07-27](/sources/web-search.md#hermes-agent-v019-quicksilver-release--source-backed-workflow-tooling-low-priority) |
|
||||
| `MiniMax-m3` | MiniMax-M3 (1M context multimodal) HuggingFace model card + Twitter launch; the daily-driver inference provider behind every OpenWiki run and most of Robin's agent work; haimaker.ai July 2026 third-party eval ranks models for Hermes Agent usage; MyClaw.ai 2026-07-29 confirms M3 + M2.7 are the operational models for both OpenClaw and Hermes, with M3 supporting multimodal (image, video, music, speech, web search) | 2026-07-16 | 2026-07-29 | watchlist | hackernews, web-search | 5 | watchlist | [HN: M3 model cluster (huggingface + twitter)](/sources/hackernews.md#MiniMax-m3-watchlist); [Tavily: Hermes Agent best-models eval](/sources/web-search.md#hermes-agent-best-models-eval-source-backed-workflow-tooling-low-priority); [Tavily: MyClaw OpenClaw vs MiniMax Agent 2026-07-29](/sources/web-search.md#2026-07-29-1803-pull) |
|
||||
| `hermes-agent-v0-19-quicksilver` | Hermes Agent v0.19 "Quicksilver" release (2026-07-25): first-token delay 4.3s → 0.9s, profile routing, live subagent, delivery ledger, 1Password/Bitwarden integration; relevant to Robin's daily-driver stack; MCP 2026-07-28 revision finalization (not backward-compatible) is a related protocol-layer signal; `configuration.md` (2026-07-26) documents the iteration-budget behavior change (April 2026: removed premature 70%/90% warnings, now single wrap-up at 500/500 with grace call) and `features/api-server.md` (2026-07-27) documents new `/v1/runs/{run_id}/stop` + `/approval` endpoints with MiniMax-M3 as the documented default model | 2026-07-25 | 2026-07-29 | source-backed | web-search | 6 | active | [Tavily: Hermes v0.19 Quicksilver + MCP revision 2026-07-27](/sources/web-search.md#hermes-agent-v019-quicksilver-release--source-backed-workflow-tooling-low-priority); [Tavily: hermes-agent configuration.md + api-server.md + MyClaw 2026-07-29](/sources/web-search.md#2026-07-29-1803-pull) |
|
||||
| `openwiki-brand` | `langchain-ai/openwiki` (96 pts) — same product family as Robin's OpenWiki; high-engagement on HN | 2026-07-16 | 2026-07-16 | source-backed | hackernews | 1 (+ 2 adjacent wrappers) | watchlist | [HN: openwiki cluster](/sources/hackernews.md#openwiki-brand-signal) |
|
||||
| `agent-memory-architecture` | Shared agent-memory architecture using Karpathy's LLM Wiki + Google's Open Knowledge Format (OKF) + MCP — let "every Local AI share ONE permanent memory"; this 2026-07-28 Tavily pull surfaces five corroborated sources (YouTube Kai, Taskade, SamurAIGPT GitHub, LinkedIn Bressler, Reddit r/ClaudeAI) on top of the three prior HN Show HN items, making this multi-source corroborated and directly adjacent to OpenWiki's role | 2026-07-26 | 2026-07-28 | source-backed | hackernews, web-search | 8+ | active | [HN: 49059959, 49059889, 49060215](/sources/hackernews.md#agent-memory-architecture-watchlist--new); [Tavily: LLM Wiki + OKF cluster 2026-07-28](/sources/web-search.md#llm-wiki--okf--shared-agent-memory-cluster--source-backed-workflow-tooling-low-priority) |
|
||||
| `agent-memory-architecture` | Shared agent-memory architecture using Karpathy's LLM Wiki + Google's Open Knowledge Format (OKF) + MCP — let "every Local AI share ONE permanent memory"; this 2026-07-29 Tavily pull adds four more corroborated sources (Hackernoon Moorcheh.ai "Agent Memory Has a Lock-In Problem. Open Formats Are How We Fix It." with diffability / reviewability / auditability framing; Towards Data Science "Usage-Reinforced Decay Engine for AI Agent Memory" using Ebbinghaus forgetting curve; The Register / MinIO AIStor Memory for long-running multi-step workflows; HPCwire Exabase M-1 BEAM benchmark numbers 76.9% / 75.0% / 68.0% at 100K/1M/10M tokens) on top of the prior HN + Tavily sources; the Hackernoon piece is the strongest OpenWiki-aligning source yet | 2026-07-26 | 2026-07-29 | source-backed | hackernews, web-search | 12+ | active | [HN: 49059959, 49059889, 49060215](/sources/hackernews.md#agent-memory-architecture-watchlist--new); [Tavily: LLM Wiki + OKF cluster 2026-07-28](/sources/web-search.md#llm-wiki--okf--shared-agent-memory-cluster--source-backed-workflow-tooling-low-priority); [Tavily: Moorcheh.ai + TDS + MinIO + Exabase cluster 2026-07-29](/sources/web-search.md#2026-07-29-1803-pull) |
|
||||
|
||||
## Notes
|
||||
|
||||
|
||||
Reference in New Issue
Block a user